- Home
- CLDI vs GDHG Comparison
CLDI vs GDHG Comparison
Compare CLDI & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- GDHG
- Stock Information
- Founded
- CLDI 2014
- GDHG 2008
- Country
- CLDI United States
- GDHG China
- Employees
- CLDI N/A
- GDHG N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- GDHG Services-Misc. Amusement & Recreation
- Sector
- CLDI Health Care
- GDHG Consumer Discretionary
- Exchange
- CLDI Nasdaq
- GDHG Nasdaq
- Market Cap
- CLDI 20.2M
- GDHG 20.5M
- IPO Year
- CLDI N/A
- GDHG 2023
- Fundamental
- Price
- CLDI $0.59
- GDHG $0.54
- Analyst Decision
- CLDI
- GDHG
- Analyst Count
- CLDI 0
- GDHG 0
- Target Price
- CLDI N/A
- GDHG N/A
- AVG Volume (30 Days)
- CLDI 51.3M
- GDHG 1.5M
- Earning Date
- CLDI 08-12-2025
- GDHG 08-12-2025
- Dividend Yield
- CLDI N/A
- GDHG N/A
- EPS Growth
- CLDI N/A
- GDHG N/A
- EPS
- CLDI N/A
- GDHG N/A
- Revenue
- CLDI N/A
- GDHG $16,666,899.00
- Revenue This Year
- CLDI N/A
- GDHG N/A
- Revenue Next Year
- CLDI N/A
- GDHG N/A
- P/E Ratio
- CLDI N/A
- GDHG N/A
- Revenue Growth
- CLDI N/A
- GDHG N/A
- 52 Week Low
- CLDI $0.20
- GDHG $0.22
- 52 Week High
- CLDI $3.89
- GDHG $209.25
- Technical
- Relative Strength Index (RSI)
- CLDI 51.83
- GDHG 28.23
- Support Level
- CLDI $0.56
- GDHG $0.44
- Resistance Level
- CLDI $0.91
- GDHG $0.61
- Average True Range (ATR)
- CLDI 0.10
- GDHG 0.17
- MACD
- CLDI -0.02
- GDHG 0.06
- Stochastic Oscillator
- CLDI 27.34
- GDHG 32.22
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.